Sowaka Reach
Used for Compassionate or named-patient use of unapproved drugs
Sowaka Reach : Expanded Access Program
A regulatory pathway that allows patients with serious or life-threatening conditions to
access investigational drugs outside of clinical trials when no alternatives are available.
Used for Compassionate or named-patient use of unapproved drugs.